Skip to main content
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.19
-0.04 (-0.64%)
At close: Mar 9, 2026, 4:00 PM EDT
6.31
+0.12 (1.94%)
After-hours: Mar 9, 2026, 5:28 PM EDT

Silence Therapeutics Revenue

In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%. Silence Therapeutics had revenue of $34.00K in the quarter ending December 31, 2025, a decrease of -99.87%.

Revenue (ttm)
$559.00K
Revenue Growth
-98.71%
P/S Ratio
523.04
Revenue / Employee
$4,819
Employees
116
Market Cap
292.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.84M28.82%
Dec 31, 202116.81M9.33M124.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
XOMA Royalty 47.11M
C4 Therapeutics 35.95M
OmniAb 18.67M
AC Immune 5.48M
Revenue Rankings

SLN News

More News